Reddy D, Carver C, Clossen B, Wu X. Extrasynaptic γ-aminobutyric acid type A receptor-mediated sex differences in the antiseizure activity of neurosteroids in status epilepticus and complex partial seizures. Epilepsia. 2019;60:730-743 pubmed publisher

Reddy D, Yoshimura R, Ramanathan G, Carver C, Johnstone T, Hogenkamp D, et al. Role of β2/3-specific GABA-A receptor isoforms in the development of hippocampus kindling epileptogenesis. Epilepsy Behav. 2018;82:57-63 pubmed publisher

D Hulst C, Heulens I, Van der Aa N, Goffin K, Koole M, Porke K, et al. Positron Emission Tomography (PET) Quantification of GABAA Receptors in the Brain of Fragile X Patients. PLoS ONE. 2015;10:e0131486 pubmed publisher

Qin M, Zeidler Z, Moulton K, Krych L, Xia Z, Smith C. Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome. Behav Brain Res. 2015;291:164-171 pubmed publisher

Gachet M, Rhyn P, Bosch O, Quednow B, Gertsch J. A quantitiative LC-MS/MS method for the measurement of arachidonic acid, prostanoids, endocannabinoids, N-acylethanolamines and steroids in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;976-977:6-18 pubmed publisher

Yum M, Lee M, Ko T, Velíšek L. A potential effect of ganaxolone in an animal model of infantile spasms. Epilepsy Res. 2014;108:1492-500 pubmed publisher

Ramaker M, Strong M, Ford M, Finn D. Effect of ganaxolone and THIP on operant and limited-access ethanol self-administration. Neuropharmacology. 2012;63:555-64 pubmed publisher

Asiedu M, Mejia G, Ossipov M, Malan T, Kaila K, Price T. Modulation of spinal GABAergic analgesia by inhibition of chloride extrusion capacity in mice. J Pain. 2012;13:546-54 pubmed publisher

Ramaker M, Ford M, Fretwell A, Finn D. Alteration of ethanol drinking in mice via modulation of the GABA(A) receptor with ganaxolone, finasteride, and gaboxadol. Alcohol Clin Exp Res. 2011;35:1994-2007 pubmed publisher

Reddy D. Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res. 2010;186:113-37 pubmed publisher

Besheer J, Lindsay T, O Buckley T, Hodge C, Morrow A. Pregnenolone and ganaxolone reduce operant ethanol self-administration in alcohol-preferring p rats. Alcohol Clin Exp Res. 2010;34:2044-52 pubmed publisher

Reddy D, Rogawski M. Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model. Epilepsy Res. 2010;89:254-60 pubmed publisher

Mares P, Stehlíková M. Anticonvulsant doses of ganaxolone do not compromise motor performance in immature rats. Neurosci Lett. 2010;469:396-9 pubmed publisher

Mares P, Kubova H, Kasal A. Anticonvulsant action of a new analogue of allopregnanolone in immature rats. Physiol Res. 2010;59:305-8 pubmed

Pieribone V, Tsai J, Soufflet C, Rey E, Shaw K, Giller E, et al. Clinical evaluation of ganaxolone in pediatric and adolescent patients with refractory epilepsy. Epilepsia. 2007;48:1870-4 pubmed

Mellon S, Gong W, Schonemann M. Endogenous and synthetic neurosteroids in treatment of Niemann-Pick Type C disease. Brain Res Rev. 2008;57:410-20 pubmed

Miura Y. [A new aspect in the research on antiepileptic drugs]. Nihon Yakurigaku Zasshi. 2007;129:111-5 pubmed

Nohria V, Giller E. Ganaxolone. Neurotherapeutics. 2007;4:102-5 pubmed

Citraro R, Russo E, di Paola E, Ibbadu G, Gratteri S, Marra R, et al. Effects of some neurosteroids injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy. Neuropharmacology. 2006;50:1059-71 pubmed

Robichaud M, Debonnel G. Allopregnanolone and ganaxolone increase the firing activity of dorsal raphe nucleus serotonergic neurons in female rats. Int J Neuropsychopharmacol. 2006;9:191-200 pubmed

Ward K, Nagilla R, Jolivette L. Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human. Xenobiotica. 2005;35:191-210 pubmed

Reddy D. Role of neurosteroids in catamenial epilepsy. Epilepsy Res. 2004;62:99-118 pubmed

Reddy D. Pharmacology of catamenial epilepsy. Methods Find Exp Clin Pharmacol. 2004;26:547-61 pubmed

Kaminski R, Livingood M, Rogawski M. Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice. Epilepsia. 2004;45:864-7 pubmed

Belelli D, Herd M. The contraceptive agent Provera enhances GABA(A) receptor-mediated inhibitory neurotransmission in the rat hippocampus: evidence for endogenous neurosteroids?. J Neurosci. 2003;23:10013-20 pubmed

Foldvary Schaefer N, Falcone T. Catamenial epilepsy: pathophysiology, diagnosis, and management. Neurology. 2003;61:S2-15 pubmed

Kaminski R, Gasior M, Carter R, Witkin J. Protective efficacy of neuroactive steroids against cocaine kindled-seizures in mice. Eur J Pharmacol. 2003;474:217-22 pubmed

Mascia M, Biggio F, Mancuso L, Cabras S, Cocco P, Gorini G, et al. Changes in GABA(A) receptor gene expression induced by withdrawal of, but not by long-term exposure to, ganaxolone in cultured rat cerebellar granule cells. J Pharmacol Exp Ther. 2002;303:1014-20 pubmed

Hsiao S, Acevedo J, DuBois D, Smith K, West J, Frye G. Early postnatal ethanol intubation blunts GABA(A) receptor up-regulation and modifies 3alpha-hydroxy-5alpha-pregnan-20-one sensitivity in rat MS/DB neurons. Brain Res Dev Brain Res. 2001;130:25-40 pubmed

Ram K, Lam G, Chien B. A high-performance liquid chromatography-tandem mass spectrometric method for the determination of pharmacokinetics of ganaxolone in rat, monkey, dog and human plasma. J Chromatogr B Biomed Sci Appl. 2001;751:49-59 pubmed

Monaghan -, McAuley -, Data -. Ganaxolone: a novel positive allosteric modulator of the GABA(A) receptor complex for the treatment of epilepsy. Expert Opin Investig Drugs. 1999;8:1663-1671 pubmed

Reddy D, Rogawski M. Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself. J Pharmacol Exp Ther. 2000;295:1241-8 pubmed

Kerrigan J, Shields W, Nelson T, Bluestone D, Dodson W, Bourgeois B, et al. Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial. Epilepsy Res. 2000;42:133-9 pubmed

Carter R, Wood P, Wieland S, Hawkinson J, Belelli D, Lambert J, et al. Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor. J Pharmacol Exp Ther. 1997;280:1284-95 pubmed